These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6530478)

  • 1. Determination of 4,5-dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3(2H)-pyridazinone hydrochloride, a new cardiotonic, in plasma and urine by reversed-phase high-performance liquid chromatography.
    Hayes AG; Mehta S; Chang T
    J Chromatogr; 1984 Dec; 336(2):446-51. PubMed ID: 6530478
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of a new inotropic agent in human plasma by high-performance liquid chromatography.
    Hsu SH; Koerper TL; Tomlinson BJ; Miksic JR; Grebow PE
    J Chromatogr; 1988 Dec; 459():215-20. PubMed ID: 3243895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotonic agents. 3. Synthesis and biological activity of novel 6-(substituted 1H-imidazol-4(5)-yl)-3(2H)-pyridazinones.
    Sircar I; Bobowski G; Bristol JA; Weishaar RE; Evans DB
    J Med Chem; 1986 Feb; 29(2):261-7. PubMed ID: 3950907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive high-performance liquid chromatographic determination of 6-(pyridin-3-yl)-quinolin-2(1H)-one and its N-oxide metabolite in rat plasma and urine.
    On NT; Damani LA; Rance DJ
    J Pharm Biomed Anal; 1993; 11(4-5):421-5. PubMed ID: 8395223
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogues of imazodan (CI-914).
    Sircar I; Morrison GC; Burke SE; Skeean R; Weishaar RE
    J Med Chem; 1987 Oct; 30(10):1724-8. PubMed ID: 3656349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated analysis of levosimendan in human plasma by on-line dialysis and liquid chromatography.
    Karlsson M; Korkolainen T; Wikberg T
    Biomed Chromatogr; 1997; 11(1):54-8. PubMed ID: 9051219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of 6-(pyridin-3-yl)quinolin-2(1H)-one, a cardiac stimulant, and its N-oxide metabolite in dog plasma by high-performance liquid chromatography.
    On NT; Damani LA; Rance DJ
    J Chromatogr; 1992 Feb; 574(2):352-5. PubMed ID: 1320044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and structure-activity relationship studies of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives as cardiotonic agents.
    Wang T; Dong Y; Wang LC; Xiang BR; Chen Z; Qu LB
    Arzneimittelforschung; 2008; 58(11):569-73. PubMed ID: 19137907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure.
    Bristol JA; Sircar I; Moos WH; Evans DB; Weishaar RE
    J Med Chem; 1984 Sep; 27(9):1099-101. PubMed ID: 6471063
    [No Abstract]   [Full Text] [Related]  

  • 10. High-performance liquid chromatographic procedure for the determination of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-(dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone, in human plasma and urine.
    Miyamoto G; Sasabe H; Odomi M; Shimizu T
    J Chromatogr; 1985 Mar; 338(2):450-5. PubMed ID: 3998030
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of 2-cyano-1-methyl-3-[4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl phenyl]guanidine in dog plasma by liquid-solid extraction and reversed-phase high-performance liquid chromatography.
    Pearce JC; Leavens WJ; McDowall RD
    J Pharm Sci; 1989 Oct; 78(10):874-6. PubMed ID: 2600797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatographic determination of indolidan and its dehydro metabolite in plasma. Use of the Varian AASP for solid-phase extraction.
    Hamilton M
    J Chromatogr; 1988 Sep; 431(1):103-11. PubMed ID: 3235521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomeric bioanalysis of simendan and levosimendan by chiral high-performance liquid chromatography.
    Wikberg T; Korkolainen T; Karlsson M
    Chirality; 1996; 8(7):511-517. PubMed ID: 8970749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic determination of 6-amidino-2-naphthyl [4-(4,5-dihydro-1H-imidazol-2-yl) amino]benzoate dimethanesulphonate and its metabolites in biological fluids.
    Marunaka T; Maniwa M; Matsushima E; Yoshida K; Azuma R; Kurotori M; Komatsu S
    J Chromatogr; 1988 Dec; 433():177-86. PubMed ID: 3266216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of a new cardiotonic agent, MDL 17,043, and its major sulfoxide metabolite in plasma by high-performance liquid chromatography.
    Chan KY; Ohlweiler DF; Lang JF; Okerholm RA
    J Chromatogr; 1984 Mar; 306():249-56. PubMed ID: 6232282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic assay of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo-[4,5-c] pyridine hydrochloride, a potent cardiotonic agent, and two metabolites in plasma.
    Bernstein JR; Franklin RB
    J Chromatogr; 1985 Jul; 342(1):228-33. PubMed ID: 3840172
    [No Abstract]   [Full Text] [Related]  

  • 17. High-performance liquid chromatographic separation of cadralazine from its potential metabolites and degradation products. Quantitation of the drug in human plasma and urine.
    Crolla T; Santini F; Visconti M; Pifferi G
    J Chromatogr; 1984 Sep; 310(1):139-49. PubMed ID: 6501510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and bioactivity of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives.
    Wang T; Dong Y; Wang LC; Chen Z
    Arzneimittelforschung; 2007; 57(10):641-6. PubMed ID: 18074757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of cadralazine in human whole blood using reversed-phase high-performance liquid chromatography: utilizing a salting-out extraction procedure.
    Rustum AM
    J Chromatogr; 1989 Apr; 489(2):345-52. PubMed ID: 2753958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of bemoradan, a long-acting inodilator in healthy males.
    Huang SM; Brusser L; Chien SC; Simon D; Smith IL; Abrams LS; Lasseter K
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):62-4. PubMed ID: 8004360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.